Bio-Techne Corp

Healthcare · Biotechnology

72.40$ -0.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Bio-Techne Corp (TECH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Total Assets" came in at 2,679 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TECH
Line item	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Total Assets	54	73	124	180	216	238	263	325	295	371	455	507	472	519	618	719	778	862	1,063	1,130	1,557	1,593	1,884	2,028	2,263	2,295	2,639	2,704	2,558	2,679
Current Assets	40	59	51	86	124	129	150	211	135	150	213	258	255	201	230	347	410	469	248	254	345	398	413	521	511	606	621	617	608	744
Cash	8.6	27	13	17	21	26	39	51	80	90	135	167	161	99	78	117	164	319	55	64	92	122	101	147	199	173	181	152	162	265
Cash & Short-Term Investments	8.6	27	29	60	97	97	118	177	97	109	165	206	203	139	141	269	333	363	111	96	158	182	166	271	232	247	204	153	162	265
Receivables	9.1	10	14	19	18	21	20	21	24	25	31	33	31	34	38	38	40	55	70	93	117	120	137	123	145	195	218	241	207	220
Inventory	4.1	3.8	5.7	4.7	5.4	6.1	6.3	7.5	7.8	9.0	8.8	9.5	11	14	45	38	35	39	50	57	60	86	91	103	117	141	172	180	189	196
Property, Plant & Equipment	–	–	–	46	49	70	81	81	89	89	92	102	100	97	95	94	109	117	130	132	135	145	154	248	282	289	226	–	–	–
Goodwill	–	–	–	–	–	–	13	13	13	25	25	25	25	25	87	86	84	151	391	431	579	598	733	728	843	822	873	973	981	975
Intangible Assets	0.4	0.3	46	36	27	19	17	15	14	6.7	5.1	4.0	3.0	2.0	52	46	41	109	293	311	452	446	579	517	616	532	535	507	366	303
Total Liabilities	5.8	9.1	27	39	38	32	27	28	27	30	17	20	16	17	32	45	41	67	216	250	606	514	719	646	692	594	672	635	639	571
Current Liabilities	4.9	7.4	14	13	16	15	11	13	14	18	17	20	16	17	18	36	32	26	40	54	135	79	102	107	152	176	129	159	176	164
Short-Term Debt	–	–	–	0.8	0.9	0.9	1.2	1.3	1.2	1.2	–	–	–	–	–	–	–	5.9	4.0	3.8	6.1	8.9	13	22	24	24	11	13	14	15
Accounts Payable	1.6	3.2	2.4	2.6	3.5	4.3	2.2	3.8	2.7	5.5	6.9	6.1	7.5	9.6	5.2	6.3	6.2	9.7	13	21	17	64	16	23	29	34	26	38	25	27
Long-Term Debt	–	–	–	19	18	17	16	15	13	12	–	–	–	–	0.0	0.0	0.0	7.0	73	92	344	339	493	344	329	243	350	319	346	200
Shareholders' Equity	48	64	97	141	178	207	237	297	268	340	438	487	456	502	586	674	738	795	847	879	951	1,079	1,166	1,381	1,563	1,702	1,967	2,069	1,919	2,108
Retained Earnings	35	49	62	88	121	147	170	223	185	232	314	359	346	400	473	520	588	653	714	771	799	877	932	1,057	1,085	1,123	1,309	1,325	1,066	1,144
Shares Outstanding	156	157	165	169	171	170	168	167	164	158	158	157	152	149	149	148	148	148	149	149	150	152	156	158	162	164	162	161	160	157

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings